GlassScriptPhysician profile
Thomas Q Kong
NPI 1881798056
$12,364.61
in general payments reported to CMS, 2019-2025
37 companies · $2,071 in 2025
The $2,071 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,357 · 2020: $244 · 2021: $1,496 · 2022: $3,199 · 2023: $2,472 · 2024: $1,525 · 2025: $2,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,022 · Education: $45.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,022.03 |
| Education | $45.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,271.66 | 2019-2025 | Lifevest |
| Abiomed | $1,198.99 | 2019-2025 | Impella |
| Amgen INC. | $1,081.21 | 2019-2025 | Repatha, Repatha, Tepezza |
| Novartis Pharmaceuticals Corporation | $1,070.27 | 2019-2025 | |
| Abbott Laboratories | $847.54 | 2019-2025 | Mitraclip, Aveir, Triclip |
| Astrazeneca Pharmaceuticals LP | $792.20 | 2020-2025 | Farxiga, Brilinta, Lokelma |
| Alnylam Pharmaceuticals INC. | $673.27 | 2022-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $666.97 | 2019-2025 | Jardiance |
| Edwards Lifesciences Corporation | $662.21 | 2022-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Merck Sharp & Dohme LLC | $596.50 | 2022-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $513.25 | 2022-2025 | Watchman Access System, Bodyguardian |
| Janssen Pharmaceuticals, INC | $465.65 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $362.63 | 2019-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $247.97 | 2021-2025 | |
| Ge Healthcare | $210.76 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $194.71 | 2019-2025 | |
| Irhythm Technologies, INC. | $186.54 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $172.87 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $148.29 | 2019-2022 | |
| Lundbeck LLC | $133.41 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $110.20 | 2024 | Arcalyst |
| Medtronic, INC. | $107.95 | 2021-2024 | Hawkone, Micra |
| Heartflow, INC. | $103.05 | 2022-2025 | Ffrct |
| W. L. Gore & Associates, INC. | $81.94 | 2025 | Gore Cardioform Septal Occluder |
| Kiniksa Pharmaceuticals, LTD. | $55.03 | 2023 | Arcalyst |
| Amarin Pharma, INC. | $53.79 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $52.43 | 2020-2022 | |
| Philips North America LLC | $45.17 | 2022 | |
| Scpharmaceuticals INC. | $40.11 | 2024-2025 | |
| La Jolla Pharmaceutical Company | $36.26 | 2022 | |
| Biotronik INC. | $35.40 | 2025 | Biomonitor, Renamic Neo |
| Lilly USA, LLC | $32.02 | 2024 | |
| Cvrx, INC. | $28.09 | 2023 | Barostim Neo System |
| Esperion Therapeutics, INC. | $23.60 | 2021 | |
| Kci USA, INC. | $21.78 | 2023 | Prevena |
| Daiichi Sankyo INC. | $21.03 | 2023 | Injectafer |
| Medtronic Vascular, INC. | $19.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.